XML 134 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Operating activities:    
Net income $ 68,373 $ 13,876
Adjustments to reconcile net income to net cash provided from operating activities:    
(Gain) loss from equity method investments, net of distributions (1,552) 2,293
Deferred income tax expense 50,314 11,164
Depletion, depreciation and amortization and impairment 235,837 208,953
Exploration dry hole costs (159) 817
Mark-to-market on natural gas, NGLs and oil derivatives not designated as hedges (62,569) (83,721)
Abandonment and impairment of unproved properties 34,374 63,930
Unrealized derivative loss 3,300 354
Allowance for bad debt 250  
Amortization of deferred financing costs, loss on extinguishment of debt and other 16,662 3,893
Deferred and stock-based compensation 63,325 26,341
(Gain) loss on the sale of assets (83,121) 13,653
Changes in working capital:    
Accounts receivable (13,997) 11,611
Inventory and other 1,545 (2,824)
Accounts payable (10,381) (21,922)
Accrued liabilities and other (22,312) 34,528
Net cash provided from operating activities 279,889 282,946
Investing activities:    
Additions to natural gas and oil properties (592,692) (781,574)
Additions to field service assets (2,033) (1,526)
Acreage purchases (27,449) (147,944)
Equity method investments 1,885  
Proceeds from disposal of assets 296,068 15,620
Purchases of marketable securities held by the deferred compensation plan (20,213) (7,872)
Proceeds from the sales of marketable securities held by the deferred compensation plan 16,342 3,590
Net cash used in investing activities (328,092) (919,706)
Financing activities:    
Borrowing on credit facilities 893,000 697,000
Repayment on credit facilities (1,323,000) (649,000)
Issuance of subordinated notes 750,000 600,000
Repayment of subordinated notes (259,063)  
Dividends paid (13,057) (12,972)
Debt issuance costs (12,324) (12,455)
Issuance of common stock 343 2,074
Change in cash overdrafts (1,155) 3,346
Proceeds from the sales of common stock held by the deferred compensation plan 13,491 8,833
Net cash provided from financing activities 48,235 636,826
Increase in cash and cash equivalents 32 66
Cash and cash equivalents at beginning of period 252 92
Cash and cash equivalents at end of period $ 284 $ 158